| Bioactivity | NU/ICRF 500 is a topo II catalytic inhibitor which increases CREST negative micronuclei in human lymphocytes[1]. |
| CAS | 156074-08-7 |
| Formula | C17H15N3O5 |
| Molar Mass | 341.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Cummings J, et al. Cytogenetic evaluation of the mechanism of cell death induced by the novel anthracenyl-amino acid topoisomerase II catalytic inhibitor NU/ICRF 500. Mutat Res. 1995 Aug;344(1-2):55-62. |